Apr 21, 2024
The Resilience of Monoclonal Antibodies and their Makers
Posted by Shubham Ghosh Roy in categories: biotech/medical, innovation
Researchers at Stanford University and Biogen faced skeptics head on, challenging the notion that monoclonal antibodies would never serve as therapeutic agents.
Read more about the journey of resilience and innovation:
The road to developing monoclonal antibodies for effectively targeting cancer was paved with tenacity, passion, and strokes of luck.
Continue reading “The Resilience of Monoclonal Antibodies and their Makers” »